Literature DB >> 17952542

Classical tandem-source dwelling covering the entire uterus: essential in modern intracavitary radiotherapy for cervical cancer?

Kiyoshi Ohara1, Keiko Nemoto, Kayoko Ohnishi, Takayuki Hashimoto, Nobuyoshi Fukumitsu, Masaharu Hata, Shinji Sugahara, Koichi Tokuuye, Yasuyuki Akine.   

Abstract

PURPOSE: We investigated whether conventional tandem-source dwelling to cover the entire uterus, classically regarded as the target volume, is necessary in modern intracavitary radiotherapy (ICRT) for cervical cancer.
MATERIALS AND METHODS: The study included 95 cervical squamous cell carcinoma patients treated by high-dose-rate ICRT (point A dose was 6.0 Gy, with three to five insertions per patient) after external beam radiotherapy (EBRT), with central pelvic doses of 12-50 Gy. The tandem-source dwell length was adjusted to the target volume specified by magnetic resonance (MR) imaging. A tandem applicator was inserted as far as the uterine fundus in accordance with the post-EBRT MR-assessed cavity length. The pre-EBRT MR-specified target volume was used for the dwell-length adjustment. The safety of the dwell-length adjustment was assessed in terms of treatment failure.
RESULTS: The dwell-length adjustment was made in 248 of 366 total insertions with a dwell-length reduction of 5-55 mm (median 15 mm) at the corpus. Pelvic failure was identified in 22 patients with a 2-year pelvic disease-free survival rate of 75.6% but without evidence of failure at dwelling-skipped corpuses.
CONCLUSION: Given after pelvic EBRT and ICRT of full-length dwelling in part, which may have eradicated possible subclinical extension, adjustment of the tandem-source dwell length to the MR-specified target volume appeared to be safe.

Entities:  

Mesh:

Year:  2007        PMID: 17952542     DOI: 10.1007/s11604-007-0154-2

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  12 in total

1.  Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation.

Authors:  C A Perez; P W Grigsby; M A Lockett; K S Chao; J Williamson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

2.  High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.

Authors:  V Lorvidhaya; A Tonusin; W Changwiwit; I Chitapanarux; J Srisomboon; S Wanwilairat; N Chawapun; V Sukthomya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

3.  The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.

Authors:  S Nag; B Erickson; B Thomadsen; C Orton; J D Demanes; D Petereit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

Review 4.  Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

Authors:  D G Petereit; R Pearcey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-15       Impact factor: 7.038

5.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.

Authors:  Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits
Journal:  Radiother Oncol       Date:  2006-01-05       Impact factor: 6.280

6.  Invasive cervical carcinoma: comparison of MR imaging and surgical findings.

Authors:  H Hricak; C G Lacey; L G Sandles; Y C Chang; M L Winkler; J L Stern
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

Review 7.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

Authors:  Christine Haie-Meder; Richard Pötter; Erik Van Limbergen; Edith Briot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Taran Paulsen Hellebust; Christian Kirisits; Stefan Lang; Sabine Muschitz; Juliana Nevinson; An Nulens; Peter Petrow; Natascha Wachter-Gerstner
Journal:  Radiother Oncol       Date:  2005-03       Impact factor: 6.280

8.  Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.

Authors:  Subir Nag; Higinia Cardenes; Silvia Chang; Indra J Das; Beth Erickson; Geoffrey S Ibbott; Jessica Lowenstein; Joye Roll; Bruce Thomadsen; Mahesh Varia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

9.  Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk.

Authors:  Johannes C A Dimopoulos; Gerdi Schard; Daniel Berger; Stefan Lang; Gregor Goldner; Thomas Helbich; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-04-01       Impact factor: 7.038

10.  Carcinoma of the cervix: staging with MR imaging.

Authors:  K Togashi; K Nishimura; T Sagoh; S Minami; S Noma; I Fujisawa; Y Nakano; J Konishi; H Ozasa; I Konishi
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

View more
  2 in total

1.  Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer.

Authors:  Sang Gyu Ju; Seung Jae Huh; Jung Suk Shin; Won Park; Heerim Nam; Sunhyun Bae; Dongryul Oh; Chae-Seon Hong; Jin Sung Kim; Youngyih Han; Doo Ho Choi
Journal:  J Radiat Res       Date:  2012-10-26       Impact factor: 2.724

2.  Evaluation of microscopic tumor extension in early-stage cervical cancer: quantifying subclinical uncertainties by pathological and magnetic resonance imaging findings.

Authors:  Naoko Sanuki; Shogo Urabe; Hideo Matsumoto; Asami Ono; Eiji Komatsu; Noritaka Kamei; Toru Maeda
Journal:  J Radiat Res       Date:  2013-02-04       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.